特奈特普酶
医学
冲程(发动机)
缺血性中风
纤溶剂
心脏病学
内科学
急诊医学
组织纤溶酶原激活剂
溶栓
缺血
心肌梗塞
机械工程
工程类
作者
Lina Palaiodimou,Aristeidis H. Katsanos,Guillaume Turc,Alexandros‐Georgios Asimakopoulos,Dimitris Mavridis,Peter D. Schellinger,Aikaterini Theodorou,Robin Lemmens,Simona Sacco,Apostolοs Safouris,Mira Katan,Amrou Sarraj,Urs Fischer,Georgios Tsivgoulis
出处
期刊:Neurology
[Ovid Technologies (Wolters Kluwer)]
日期:2024-10-16
卷期号:103 (9): e209903-e209903
被引量:65
标识
DOI:10.1212/wnl.0000000000209903
摘要
The updated meta-analysis confirms similar safety between TNK 0.25 mg/kg and TPA, while showing that TNK is superior to TPA regarding excellent functional outcome and reduced disability at 3 months. These findings support transitioning to TNK in clinical practice.
科研通智能强力驱动
Strongly Powered by AbleSci AI